This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Thursday's ETF Winners & Losers

Exchange-traded funds tracking homebuilders were among the top performers of Friday's session. Among homebuilder names, Standard Pacific (SPF) was up 2.8%, Hovnanian (HOV) was adding 2.3%, Beazer Homes (BZH) was higher by 2.1%, and Toll Brothers (TOL) was rising 1.3%.

The iShares Dow Jones U.S. Home Construction (ITB) ETF was recently up 1.4%, or 47 cents, to $34.49. The SPDR Homebuilders (XHB) ETF was climbing 35 cents, or 1.1%, to $32.75.

The Biotech HOLDRs (BBH) ETF was also rising. Holding Amgen (AMGN) was gaining 3.2%, and the Biotech HOLDRs was recently higher by $1.53, or 0.9%, to $179.80.

Other biotech ETFs were gaining ground. The iShares Nasdaq Biotechnology (IBB) ETF was up 1.3% to $78.42, the First Trust Amex Biotechnology Index (FBT) was gaining 1.2% to $24.53, and the SPDR S&P Biotech Index (XBI) was rising 1.1% to $49.73.

Also among winners, the PowerShares Lux Nanotech (PXN) ETF rose as holding Altair Nanotechnologies (ALTI) jumped 6.4%. The ETF was recently up 11 cents, or 0.6%, to $17.36.

On the flip side, bundled securities tracking the energy sector were among the worst performers of the day. The front-month May crude contract continued to ease a day after Iran's President Mahmoud Ahmadinejad freed 15 British sailors and marines the country captured last month in the Persian Gulf. Crude prices were recently losing 34 cents at $64.04 a barrel.

The iPath Goldman Sachs Crude Oil Index (OIL) ETF eased 0.8% to $37.98. The United States Oil (USO) ETF was recently down 0.7% to $51.99.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,660.56 -12.04 -0.07%
S&P 500 2,053.07 +1.25 0.06%
NASDAQ 4,762.2810 +4.4020 0.09%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs